Condensed Statement of Changes in Shareholders’ Equity (Deficit) (Unaudited) - 3 months ended Mar. 31, 2026 - USD ($)	Class A Ordinary Shares	Class B Ordinary Shares	[1]	Additional Paid-in Capital	(Accumulated Deficit) Retained Earnings	Total
Balance at Dec. 31, 2025		$ 843		$ 24,157	$ (83,209)	$ (58,209)
Balance (in Shares) at Dec. 31, 2025		8,433,333
Accretion of Class A ordinary shares subject to redemption amount				18,144,576		(18,144,576)
Sale of Private Placement Warrants				5,000,000		5,000,000
Fair value of Public Warrants at issuance				4,048,000		4,048,000
Fair value of Representative Shares	$ 100			9,839,900		9,840,000
Fair value of Representative Shares (in Shares)	1,000,000
Allocated value of transaction costs to Class A shares				(402,601)		(402,601)
Net Income (Loss)					1,684,199	1,684,199
Balance at Mar. 31, 2026	$ 100	$ 843		$ 364,880	$ 1,600,990	$ 1,966,813
Balance (in Shares) at Mar. 31, 2026	1,000,000	8,433,333

[1] As of December 31, 2025, includes up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). On January 8, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,100,000 Founder Shares are no longer subject to forfeiture.